KFFs annual employer health benefits survey found premiums for employer coverage increased in 2025 and are expected to increase further in 2026, with employers noting similar cost pressures such as new prescription drugs, prevalence of chronic disease, and higher utilization of services
This integrated approach aimed to elucidate the renoprotective effects of AST and provide new insights into its therapeutic potential in CKD
Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care-clinically relevant 3PM innovation
Whether youre exploring Semaglutide or other services, well be with you every step of the way, ensuring you have a smooth, satisfying experience
Their metabolic and anti-inflammatory actions position them as candidates to treat some of the pathophysiology exhibited in many people with lipedema, particularly when insulin resistance or excess adiposity is comorbid
